VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Questions for Alvira at the AGM

<< Previous

Bullboard Posts

Next >>

Post by shawshank666on Oct 26, 2023 10:30am

116 Views

Post# 35702016

Questions for Alvira at the AGM

1. Where is the money from those 6 purchase orders received in 2022?
2. Out of the 3-4 demos a month, what percentage of demos result in a sale?(it's not 100%)
3, From the Sept.6 corporate update, what happened to the over 10 purchase orders pending?
4. From the Sept. 6 corporate update, what happened to the 8 outstanding quotes?
5. Why aren't people buying the VMS if there's been so much positive comments received at these conferences?
6. Are there sales happening but you are not reporting them?

<< Previous

Bullboard Posts

Next >>

2024, a breakthrough year for silver